Sign in
4

Changes in Ownership

TuHURA Biosciences, Inc./NV Filed Acc 0001213900-17-006200

Chief Financial Officer bought 9,500 shares at $2.10 ($19,950)

From the SEC's structured data for this filing

Trades in this filing

Praill Scott · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-06-06 Purchase : show line 1 in the form +9,500 $2.10 $19,950 25,277 D
Open-market purchases · 9,500 sh · avg $2.10 · $19,950
Loading xslF345X03/f4060617praill_delmarpharma.xml…